PHOENIX, AZ (October 30, 2024) – Nicholas Banovich, Ph.D., associate professor and division director of Bioinnovation and Genome Sciences at TGen, part of City of Hope, will lead or co-lead three collaborative grants totaling over $22 million, with $8.2 million supporting research at TGen. These grants, awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI), will support innovative research to uncover the molecular drivers of pulmonary diseases, with the goal of improving prevention, diagnosis, and treatment.Continue reading
Author Archive: AZBio
Accomplished scientist and executive Díaz de la Rubia selected to lead U of A research enterprise
Accomplished scientist and executive Díaz de la Rubia selected to lead U of A research enterpriseContinue reading
TGen and partners in Longevity Consortium receive $45 million grant
The five-year grant will integrate studies of factors contributing to longer and healthier livesContinue reading
Soteria Precision Medicine Foundation Partners with Translational Genomics Research Institute (TGen) to Inform Cancer Care for Special Operations Forces
Effort will provide leading-edge precision medicine navigation for Special Operation Forces in their battle against cancer through comprehensive genomic testing and analysis conducted by TGenContinue reading
Nucleus RadioPharma Announces New Manufacturing Site In Mesa
Facility will put high-quality development and manufacturing for short half-life theranostic products within reachContinue reading
Former Speaker of the House Kevin McCarthy Appointed to Anivive’s Board of Directors
McCarthy’s extensive experience in government and advocacy for Valley Fever will play a pivotal role in the launch of the world’s first fungal vaccine.Continue reading
Arizona Alzheimer’s Consortium (AAC) Biomarker Measurement Support Request for Proposals
The Arizona Alzheimer’s Consortium (AAC) invites applications for biofluid biomarker analysis to advance the understanding of neurodegenerative disorders. These biomarker analyses will be conducted at the Biomarker Laboratory at Banner Sun Health Research Institute. The objective is to foster cutting-edge research that provides meaningful insights into Alzheimer’s disease and related dementias through the use of advanced biomarker platforms.Continue reading
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48
– Novel Investigational Combination Regimen is Advancing to Phase 3 and has the Potential to Become the First Weekly Oral HIV Treatment –Continue reading
Anthem Blue Cross and Blue Shield Foundation Launches Groundbreaking Effort with Long-time Partner Open Table to Address Substance Use Disorder Among Young People
Woodstock, VA –As part of its parent company’s three-year, $30 million commitment to programs supporting mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation unveiled an initiative in Shenandoah County, Virginia, to address the substance use disorder crisis among children and adolescents. Through a $750,000 grant awarded to its long-standing non-profit partner, The Open Table, Inc., Anthem has funded an initiative focused on “Strengthening Shenandoah” – an effort supporting the Shenandoah Juvenile and Domestic Relations Court, Shenandoah County Public Schools, Life Enrichment Services, and Strength in Peers.Continue reading